Exorcist lets U.S. soldiers put new spin on time in Iraq

Breathing new fire into the old cliches that war is hell and love of money is the root of all evil, American soldiers have found a way to wrest Western capitalism out of the Iraqi sands where part of Hollywood’s most popular devil movie was filmed…

Last month, Capt. Nik Guran of the 2-320 Field Artillery Regiment, a ‘major unit’ of the 101st Airborne Division stationed in the small Iraqi town of Hatra, inserted a copy of The Exorcist in a portable DVD player. As the film began, Guran had the weird realization he was sitting at the location where director William Friedkin shot the opening sequence of his 1973 horror classic.


‘He recognized the sun temples,’ Friedkin recently said by phone from Hollywood.


‘And then the Army hatched this idea,’ Friedkin continued, ‘to turn the whole area into a tourist attraction and call it ‘The Exorcist Experience.”” —Houston Chronicle [via walker]

R.I.P. Janet Frame, 79

//graphics7.nytimes.com/images/2004/01/30/arts/Frame184.jpg' cannot be displayed]

New Zealand Writer Who Explored Madness Dies: “Ms. Frame created romantic visionaries — eccentrics, mad people, epileptics — and pitted them against the repressive forces of a sterile, conformist society. Or maybe she was just reporting on her life. A continuing discussion among critics was whether her autobiographical work was mostly fiction or whether her fiction was mostly autobiographical.” Suffering a nervous breakdown and making a suicide attempt, she was institutionalized, underwent numerous ECT (electroshock) treatments, and was on the point of receiving a lobotomy when consultants said her diagnosis of schizophrenia had been a mistake. Frame lamented, “Oh why had they robbed me of my schizophrenia, which had been the answer to all my misgivings about myself?” A panel of psychiatrists later ruled that the exquisitely shy writer was, in the terms of this New York Times obituary, “not mentally ill, just different from other people”. Her autobiography, in many ways perhaps more comfortable for her readers than her fiction, was adapted into Jane Campion’s 1990 film, An Angel at My Table. She has often been discussed as a candidate for the Nobel literature prize. She succumbed to acute myeloid leukemia, with which she had been diagnosed on her birthday last August.

“”For your own good” is a persuasive argument

that will eventually make a man agree to his own destruction.”

— Janet Frame, Faces In The Water (1982)

This fascinating article by Tara Hawes from the University of Otago, NZ, explores Frame’s torment about who she was (or wasn’t), her obsession with the autobiographical ‘I’ and the process Hawes calls ‘selfing the other and othering the self’ throughout Frame’s oeuvre.

Black and Bruised

“The African-American vote could make all the difference in South Carolina. But given the way three local Democratic activists are feeling, the party might be in big trouble… The Democratic Party is the party that talks about the black vote and attaining it by any means necessary,” Aiken said. ”Now, that does not equate with ‘We value the black vote’ as much as ‘We have to attain it in order to get what we want.”’ The routine currency in this exchange is emotion — for white candidates a little soul power soaked up from a gospel choir and shed just as easily. Candidates parade through church, Aiken noted, but, she said: ”Has anyone done a follow-up visit after a campaign? You know, ‘I came to your church, asked for your vote, the preacher gave me the pat and we prayed. Now I’m in; I’m going to make one more trip back, at least to thank you.”'” —New York Times Magazine

Bush OK’s Independent Probe of Prewar Intelligence

Bowing to pressure from lawmakers, the White House reverses its opposition to an independent investigation of intelligence failures. —Washington Post. Right now, administration strategy is all about damage control; Bush’s team appears divided over whether it would be worse to acknowledge that the data on which it based its decision was wrong, or to remain ‘publicly agnostic’ about the quality of the intelligence. The thing to watch will be how the administration limits both the scope (will the inquiry address not only generation but administration consumption of intelligence data?) and duration of the investigation. Rather than making this go away quickly, an effort that the White House reversal seems to acknowledge has failed, they may try to draw this out so any damaging allegations do not come out until after November. Expect the White House to drag its feet mightily in cooperating with requests for crucial data from an independent commission.

Monsanto’s chapati patent raises Indian ire

“Monsanto, the world’s largest genetically modified seed company, has been awarded patents on the wheat used for making chapati – the flat bread staple of northern India.


The patents give the US multinational exclusive ownership over Nap Hal, a strain of wheat whose gene sequence makes it particularly suited to producing crisp breads.


Another patent, filed in Europe, gives Monsanto rights over the use of Nap Hal wheat to make chapatis, which consist of flour, water and salt.


Environmentalists say Nap Hal’s qualities are the result of generations of farmers in India who spent years crossbreeding crops and collective, not corporate, efforts should be recognised.” —Guardian.UK This would be like patenting the use of flour to make pizza dough in the US.

Making Drugs, Shaping the Rules

In examining the insidious marketing strategies Big Pharma uses to put profits ahead of people’s health, I have often noted the lack of a constituency for patients with the devastating disease on which I focus most, chronic schizophrenia. This article focuses on the challenges the drug companies face in marketing newly-developed (and monumentally expensive) antipsychotic drugs for this population.

Since the mid-1990’s, a group of drug companies, led by Johnson & Johnson, has campaigned to convince state officials that a new generation of drugs – with names like Risperdal, Zyprexa and Seroquel – is superior to older and much cheaper antipsychotics like Haldol. The campaign has led a dozen states to adopt guidelines for treating schizophrenia that make it hard for doctors to prescribe anything but the new drugs. That, in turn, has helped transform the new medicines into blockbusters.

Ten drug companies chipped in to help underwrite the initial effort by Texas state officials to develop the guidelines. Then, to spread the word, Johnson & Johnson, Pfizer and possibly other companies paid for meetings around the country at which officials from various states were urged to follow the lead of Texas, according to documents and interviews that are part of a lawsuit and an investigation in Pennsylvania. —New York Times

The marketing pressure the manufacturers exerted allegedly includes payoffs and other illegal or marginally legal practices. In comparative studies, these drugs have comparable efficacy to the older antipsychotics. Early claims that they are more effective have gone by the boards. Pitching them to prescribers has largely relied on claims that they are better tolerated and safer than the older drugs in terms of side effects. While this is true (patients on them develop the devastating neurological effects of the older drugs far less often), they turn out to have important metabolic complications (effects on glucose and lipid metabolism, weight gain and in some cases cardiac risks). Psychiatrists like myself and other physicians are the objects of a relentless full court press from the manufacturers to diffuse prescribers’ concerns about such liabilities to their patients. Suffice it to say that physicians should be collectively ashamed of how they have handed control over what they learn about prescribing new medications to the pharmaceutical companies that profit from those drugs.